top of page

Boehringer Ingelheim, a renowned player in the animal health industry, has exciting news to share with cat owners and veterinary professionals worldwide. They have recently unveiled their latest development in feline healthcare—the highly anticipated 0.5 ml presentation of the Purevax® vaccine range specifically designed for cats. This groundbreaking launch aims to revolutionize the way cats are vaccinated by providing a more convenient and gentle immunization experience for our beloved feline companions.

The official launch of this groundbreaking innovation took place in 2022, where industry experts, veterinarians, and esteemed guests gathered at the prestigious Grand Hyatt Hotel. The event served as a platform for Boehringer Ingelheim to showcase the potential impact of the 0.5 ml presentation of Purevax® on feline healthcare. With engaging presentations and informative discussions, the launch successfully highlighted the key advantages and features of this new vaccine range.

Purevax
Purevax
Purevax
Purevax
Purevax
Purevax
MASTERPIECES-2.png

Purevax Launch

Contact

Like what you see? Get in touch to learn more.

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Brillions International Sdn Bhd (133148A-A)

                                   

Main Office

Tower B-15-13, Menara Prima, 

Jalan PJU1/39, Dataran Prima,

47301, Petaling Jaya, Selangor. 

Factory

AL294-C Jalan Kampung,

Kampung Batu Sg. Buloh

47000 Sungai Buloh,

Selangor.

+6012-373-1718
Picture9.png
bottom of page